← Back to guidelines
Pediatrics11 papers

Non-anemic red cell disorder

Last edited: 4/15/2026

Overview

Non-anemic red cell disorders encompass a range of hematologic conditions affecting red blood cells without causing anemia, impacting patient quality of life and requiring specific monitoring and management strategies 1.

Diagnosis

  • Utilization of patient-reported outcome measures (PROMs) to assess health-related quality of life in pediatric patients 1.
  • Specific PROMs like the Pediatric Quality of Life Generic Core Scales are frequently employed for comprehensive evaluation 1.
  • Management

  • Focus on symptom management and quality of life improvement through validated PROMs rather than specific pharmacological treatments mentioned in the abstract 1.
  • Tailored interventions based on disease-specific PROMs to address individual patient needs 1.
  • Special Populations

  • Pediatrics: Emphasis on using validated PROMs to monitor health outcomes and quality of life in pediatric patients with non-malignant hematologic disorders 1.
  • Key Recommendations

  • Incorporate patient-reported outcome measures (PROMs) in the clinical assessment of pediatric patients with non-anemic red cell disorders to enhance monitoring of health-related quality of life 1 (Evidence: Strong).
  • Utilize generic PROMs like the Pediatric Quality of Life Generic Core Scales for broad applicability across different non-malignant hematologic conditions 1 (Evidence: Strong).
  • Select disease-specific PROMs when available to provide more targeted assessments of patient experiences 1 (Evidence: Moderate).
  • References

    1 Kinahan JY, Graham JMI, Hébert YV, Sampson M, O'Hearn K, Klaassen RJ. Patient-reported Outcome Measures in Pediatric Non-Malignant Hematology: A Systematic Review. Journal of pediatric hematology/oncology 2021. link

    Original source

    1. [1]
      Patient-reported Outcome Measures in Pediatric Non-Malignant Hematology: A Systematic Review.Kinahan JY, Graham JMI, Hébert YV, Sampson M, O'Hearn K, Klaassen RJ Journal of pediatric hematology/oncology (2021)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG